-
COVID-19 antivirals access criteria (includes Paxlovid)
Access criteria for nirmatrelvir with ritonavir (Paxlovid), and remdesivir (Veklury)
-
Paxlovid (COVID-19 antiviral) access criteria assessment tool
-
Identifying people at high risk for severe illness from COVID-19
-
Severely immunocompromised for access to COVID-19 antiviral treatments
-
Remdesivir: access criteria for COVID-19 treatment in hospitalised patients
-
Remdesivir (Veklury) - hospital access criteria assessment tool
-
Access criteria for treatments for persistent SARS-CoV-2 infection